| Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial M Azizi, K Sanghvi, M Saxena, P Gosse, JP Reilly, T Levy, LC Rump, ... The Lancet 397 (10293), 2476-2486, 2021 | 231 | 2021 |
| Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in … C Arsov, R Rabenalt, D Blondin, M Quentin, A Hiester, E Godehardt, ... European urology 68 (4), 713-720, 2015 | 214 | 2015 |
| Prediction of high-grade prostate cancer following multiparametric magnetic resonance imaging: improving the Rotterdam European randomized study of screening for prostate … AR Alberts, MJ Roobol, JFM Verbeek, IG Schoots, PK Chiu, DF Osses, ... European urology 75 (2), 310-318, 2019 | 169 | 2019 |
| Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard L Schimmöller, M Quentin, C Arsov, RS Lanzman, A Hiester, R Rabenalt, ... European radiology 23, 3185-3190, 2013 | 138 | 2013 |
| Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with … M Quentin, D Blondin, C Arsov, L Schimmöller, A Hiester, E Godehardt, ... The Journal of urology 192 (5), 1374-1379, 2014 | 121 | 2014 |
| MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy L Schimmöller, M Quentin, C Arsov, A Hiester, C Buchbender, R Rabenalt, ... European radiology 24, 2582-2589, 2014 | 112 | 2014 |
| Magnetic resonance imaging of the prostate at 1.5 versus 3.0 T: A prospective comparison study of image quality T Ullrich, M Quentin, C Oelers, F Dietzel, LM Sawicki, C Arsov, R Rabenalt, ... European journal of radiology 90, 192-197, 2017 | 101 | 2017 |
| Feasibility of diffusional kurtosis tensor imaging in prostate MRI for the assessment of prostate cancer: preliminary results M Quentin, G Pentang, L Schimmöller, O Kott, A Müller-Lutz, D Blondin, ... Magnetic resonance imaging 32 (7), 880-885, 2014 | 84 | 2014 |
| MRI-guided in-bore biopsy: differences between prostate cancer detection and localization in primary and secondary biopsy settings L Schimmöller, D Blondin, C Arsov, R Rabenalt, P Albers, G Antoch, ... American Journal of Roentgenology 206 (1), 92-99, 2016 | 75 | 2016 |
| The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy C Arsov, N Becker, R Rabenalt, A Hiester, M Quentin, F Dietzel, G Antoch, ... Journal of cancer research and clinical oncology 141, 2061-2068, 2015 | 65 | 2015 |
| Joint imaging platform for federated clinical data analytics J Scherer, M Nolden, J Kleesiek, J Metzger, K Kades, V Schneider, ... JCO clinical cancer informatics 4, 1027-1038, 2020 | 54 | 2020 |
| Prospective comparison of whole-body MRI and 68Ga-PSMA PET/CT for the detection of biochemical recurrence of prostate cancer after radical prostatectomy LM Sawicki, J Kirchner, C Buddensieck, C Antke, T Ullrich, L Schimmöller, ... European Journal of Nuclear Medicine and Molecular Imaging 46, 1542-1550, 2019 | 53 | 2019 |
| Predictive power of the ESUR scoring system for prostate cancer diagnosis verified with targeted MR-guided in-bore biopsy L Schimmöller, M Quentin, C Arsov, A Hiester, P Kröpil, R Rabenalt, ... European journal of radiology 83 (12), 2103-2108, 2014 | 52 | 2014 |
| Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostate T Ullrich, M Quentin, AK Schmaltz, C Arsov, C Rubbert, D Blondin, ... European Radiology 28, 17-23, 2018 | 46 | 2018 |
| Risk stratification of equivocal lesions on multiparametric magnetic resonance imaging of the prostate T Ullrich, M Quentin, C Arsov, AK Schmaltz, A Tschischka, N Laqua, ... The Journal of urology 199 (3), 691-698, 2018 | 45 | 2018 |
| Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary … NM Bruckmann, J Kirchner, L Umutlu, WP Fendler, R Seifert, K Herrmann, ... European radiology 31 (11), 8714-8724, 2021 | 42 | 2021 |
| Secondary sclerosing cholangitis as a complication of severe COVID‐19: A case report and review of the literature C Klindt, BE Jensen, T Brandenburger, T Feldt, A Killer, L Schimmöller, ... Clinical Case Reports 9 (5), e04068, 2021 | 38 | 2021 |
| A randomized trial of risk‐adapted screening for prostate cancer in young men—Results of the first screening round of the PROBASE trial C Arsov, P Albers, K Herkommer, J Gschwend, F Imkamp, I Peters, ... International Journal of Cancer 150 (11), 1861-1869, 2022 | 37 | 2022 |
| Multiparametric magnetic resonance imaging/ultrasound fusion prostate biopsy—are 2 biopsy cores per magnetic resonance imaging lesion required? P Dimitroulis, R Rabenalt, A Nini, A Hiester, I Esposito, L Schimmöller, ... The Journal of urology 200 (5), 1030-1034, 2018 | 35 | 2018 |
| Patient-level pooled analysis of ultrasound renal denervation in the sham-controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO trials AJ Kirtane, ASP Sharp, F Mahfoud, NDL Fisher, RE Schmieder, ... JAMA cardiology 8 (5), 464-473, 2023 | 33 | 2023 |
